197 related articles for article (PubMed ID: 31807428)
1. Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity.
Shi C; Chen X; Tan D
Transl Androl Urol; 2019 Oct; 8(5):519-528. PubMed ID: 31807428
[TBL] [Abstract][Full Text] [Related]
2. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
3. Application of Organoid Models in Prostate Cancer Research.
Zhou L; Zhang C; Zhang Y; Shi C
Front Oncol; 2021; 11():736431. PubMed ID: 34646778
[TBL] [Abstract][Full Text] [Related]
4. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
5. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenografts as compatible models for precision oncology.
Cho SY
Lab Anim Res; 2020; 36():14. PubMed ID: 32461927
[TBL] [Abstract][Full Text] [Related]
7. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
8. An original patient-derived xenograft of prostate cancer with cyst formation.
Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
[TBL] [Abstract][Full Text] [Related]
9. Genetic heterogeneity and clonal evolution during metastasis in breast cancer patient-derived tumor xenograft models.
Sprouffske K; Kerr G; Li C; Prahallad A; Rebmann R; Waehle V; Naumann U; Bitter H; Jensen MR; Hofmann F; Brachmann SM; Ferretti S; Kauffmann A
Comput Struct Biotechnol J; 2020; 18():323-331. PubMed ID: 32099592
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX.
Rea D; Del Vecchio V; Palma G; Barbieri A; Falco M; Luciano A; De Biase D; Perdonà S; Facchini G; Arra C
Biomed Res Int; 2016; 2016():9750795. PubMed ID: 27294148
[TBL] [Abstract][Full Text] [Related]
11. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.
Liu X; Chen X; Rycaj K; Chao HP; Deng Q; Jeter C; Liu C; Honorio S; Li H; Davis T; Suraneni M; Laffin B; Qin J; Li Q; Yang T; Whitney P; Shen J; Huang J; Tang DG
Oncotarget; 2015 Sep; 6(27):23959-86. PubMed ID: 26246472
[TBL] [Abstract][Full Text] [Related]
12. Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer.
Lange T; Oh-Hohenhorst SJ; Joosse SA; Pantel K; Hahn O; Gosau T; Dyshlovoy SA; Wellbrock J; Feldhaus S; Maar H; Gehrcke R; Kluth M; Simon R; Schlomm T; Huland H; Schumacher U
Sci Rep; 2018 Dec; 8(1):17535. PubMed ID: 30510249
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma.
Xin Y; Li S; Jiang Q; Hu F; He Y; Zhang J
Front Oncol; 2020; 10():1479. PubMed ID: 32974176
[No Abstract] [Full Text] [Related]
14. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Mo F; Lin D; Takhar M; Ramnarine VR; Dong X; Bell RH; Volik SV; Wang K; Xue H; Wang Y; Haegert A; Anderson S; Brahmbhatt S; Erho N; Wang X; Gout PW; Morris J; Karnes RJ; Den RB; Klein EA; Schaeffer EM; Ross A; Ren S; Sahinalp SC; Li Y; Xu X; Wang J; Wang J; Gleave ME; Davicioni E; Sun Y; Wang Y; Collins CC
Eur Urol; 2018 Apr; 73(4):524-532. PubMed ID: 28330676
[TBL] [Abstract][Full Text] [Related]
15. New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine.
Rago V; Perri A; Di Agostino S
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893116
[TBL] [Abstract][Full Text] [Related]
16. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment.
Fujii E; Kato A; Suzuki M
J Toxicol Pathol; 2020 Jul; 33(3):153-160. PubMed ID: 32764840
[TBL] [Abstract][Full Text] [Related]
18. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
Kawaguchi T; Foster BA; Young J; Takabe K
J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
[TBL] [Abstract][Full Text] [Related]
19. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer.
Jansson KH; Tucker JB; Stahl LE; Simmons JK; Fuller C; Beshiri ML; Agarwal S; Fang L; Hynes PG; Alilin AN; Lake R; Abbey YC; Cawley J; Tice CM; Yin J; McKnight C; Klummp-Thomas C; Zhang X; Guha R; Hoover S; Simpson RM; Nguyen HM; Corey E; Thomas CJ; Proia DA; Kelly K
Sci Rep; 2018 Nov; 8(1):17239. PubMed ID: 30467317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
